Cardiovascular Toxicities of Ibrutinib: A Pharmacovigilance Study Based on the United States Food and Drug Administration Adverse Event Reporting System Database

• Main Authors: Yi Zheng (Author), Xiaojing Guo (Author), Chenxin Chen (Author), Lijie Chi (Author), Zhijian Guo (Author), Jizhou Liang (Author), Lianhui Wei (Author), Xiao Chen (Author), Xiaofei Ye (Author), Jia He (Author)
• Format: Book
• Published: MDPI AG, 2023-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Although ibrutinib has been widely used to treat haematological malignancies, many studies have reported associated cardiovascular events. These studies were primarily animal experiments and clinical trials. For more rational clinical drug use, a study based on post-marketing data is nec...